Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics

[1]  L. Staudt.  Molecular diagnosis of the hematologic cancers. , 2003, The New England journal of medicine.

[2]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[3]  M. Nussenzweig,et al.  Mannose Receptor-Mediated Regulation of Serum Glycoprotein Homeostasis , 2002, Science.

[4]  S Chevret,et al.  Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial , 2002, Journal of viral hepatitis.

[5]  H. Adami,et al.  The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis , 2001, Hepatology.

[6]  T. Nikaido,et al.  Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes. , 2001, Biochemical and biophysical research communications.

[7]  R. Contreras,et al.  Ultrasensitive profiling and sequencing of N-linked oligosaccharides using standard DNA-sequencing equipment. , 2001, Glycobiology.

[8]  F. Degos,et al.  Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey , 2000, Hepatology.

[9]  P. Kamath,et al.  Managing the complications of cirrhosis. , 2000, Mayo Clinic proceedings.

[10]  H. Fusamoto,et al.  Gene expression of N‐acetylglucosaminyltransferases III and V: A possible implication for liver regeneration , 1995, Hepatology.

[11]  C. Tiribelli,et al.  Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study , 1994, Hepatology.

[12]  P. Bedossa,et al.  Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .

[13]  Henderson Ar,et al.  Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. , 1993 .

[14]  A R Henderson,et al.  Assessing Test Accuracy and its Clinical Consequences: A Primer for Receiver Operating Characteristic Curve Analysis , 1993, Annals of clinical biochemistry.

[15]  H Stibler,et al.  Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. , 1991, Clinical chemistry.

[16]  S. Fujii,et al.  N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[17]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[18]  Y. Tashiro,et al.  Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma: Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma , 1984 .

[19]  S. Hanash,et al.  Disease proteomics , 2003, Nature.

[20]  Henrik Antti,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2003, Nature Medicine.

[21]  M. Colombo,et al.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. , 1986, Journal of hepatology.

[22]  H. Nakada,et al.  Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. , 1984, Gastroenterology.

[23]  G. Ashwell,et al.  Carbohydrate-specific receptors of the liver. , 1982, Annual review of biochemistry.